Education
About Us
Working with TipRanks
Follow Us
Scandion Oncology A/S (SE:SCOL)
:SCOL
RESEARCH TOOLSreports
SCOL Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.24
Previous CloseN/A
Volume809.02K
Average Volume (3M)2.54M
Market Cap
$962.52K
Enterprise Value-$11.98M
Total Cash (Recent Filing)$12.69M
Total Debt (Recent Filing)kr66.00K
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding234,761,410
10 Day Avg. Volume1,890,051
30 Day Avg. Volume2,543,284
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.08
Price to Sales (P/S)0.00
P/FCF Ratio-0.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SCOL FAQ
What was Scandion Oncology A/S’s price range in the past 12 months?
Scandion Oncology A/S lowest stock price was <$0.01 and its highest was $0.24 in the past 12 months.
What is Scandion Oncology A/S’s market cap?
Scandion Oncology A/S’s market cap is $962.52K.
When is Scandion Oncology A/S’s upcoming earnings report date?
Scandion Oncology A/S’s upcoming earnings report date is Aug 28, 2025 which is in 32 days.
How were Scandion Oncology A/S’s earnings last quarter?
Currently, no data Available
Is Scandion Oncology A/S overvalued?
According to Wall Street analysts Scandion Oncology A/S’s price is currently Overvalued.
Does Scandion Oncology A/S pay dividends?
Scandion Oncology A/S does not currently pay dividends.
What is Scandion Oncology A/S’s EPS estimate?
Scandion Oncology A/S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scandion Oncology A/S have?
Scandion Oncology A/S has 234,761,410 shares outstanding.
What happened to Scandion Oncology A/S’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scandion Oncology A/S?
Currently, no hedge funds are holding shares in SE:SCOL
Company Description
Scandion Oncology A/S
Scandion Oncology A/S (SCOL) is a biotechnology company specializing in developing innovative treatments to overcome drug resistance in cancer therapy. The company focuses on creating and advancing pharmaceutical solutions that enhance the effectiveness of existing cancer treatments. Scandion Oncology's core product portfolio includes proprietary drug candidates designed to counteract resistance mechanisms in cancer cells, thus improving patient outcomes in oncology sectors.